NCT05621837View on ClinicalTrials.gov

Quantifying Systemic Immunosuppression to Personalize Cancer Therapy

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

March 10, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
MelanomaBreast CancerRenal Cell CarcinomaUrinary Bladder CancerSquamous Cell Carcinoma of Head and NeckSmall Cell CarcinomaNSCLC
Interventions
OTHER

MDSC quantification

Blood sample will be collected at baseline and during therapy, and, optionally, in case of disease progression (PD).

Trial Locations (1)

20033

RECRUITING

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

All Listed Sponsors
lead

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

OTHER